New inhibitors of HIV based on cellular enzymes [ 2007-01-01 - 2008-12-31 ]

Research Grant

Researchers: Dr Heung Cheng (Chief Investigator) ,  Dr Terrence Mulhern (Chief Investigator) ,  ARC Linkage Grant LP1701000985 (Funded by) ,  Prof Thomas Smithgall (Overseas Investigator)

Brief description New inhibitors of HIV based on cellular enzymes. Over 39 million people are infected with HIV worldwide. However, none of the most highly affected countries have yet reached the peak in AIDS-related illness and death, thus the global impact of HIV/AIDS will get significantly worse, before it gets better.\r\n\r\nIn Australia, HIV is again on the rise. Ironically, improved treatments that have extended life expectancy will cause the number of HIV infected Australians to rise for many years to come. Therefore many Australians will suffer from the combined impact of the AIDS illness itself, opportunistic infections, the side-effects of treatment and natural aging. We aim to develop new drugs to combat this disease to help people everywhere lead happier, healthier and more productive lives.

Funding Amount $13,000

Funding Scheme Linkage - International

View this grant in the ARC Data Portal